In patients with PSC-IBD, serum Cer d18:1;O2/24:0 was markedly decreased in comparison to patients with IBD (Fig. 1A), whereas CRP and fecal calprotectin levels between these groups were similar (Table 1). This evidence concerns the gene CBLN1 and pancreatic serous cystadenoma.